Loss of CaMK2B accelerates tumor formation and enhances metastatic competency in genetically engineered mouse models of PDAC

被引：0
|
作者：
Peura, Jessica
Bhalerao, Nikita
Johnson, Calvin
Ogoti, Yamini
Keller, Faith
Watson, Emma
Zhao, Zhen
Pitarresi, Jason
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-C061
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C061
引用
收藏
页数：2
相关论文
共 7 条
  • [1] REDUCTION OF TUMOR BURDEN AND HEARING LOSS WITH A MULTIPLE RECEPTOR TYROSINE KINASE INHIBITOR BRIGATINIB IN A GENETICALLY ENGINEERED MOUSE MODEL OF NEUROFIBROMATOSIS TYPE 2
    Smith, Abbi
    Bessler, Waylan
    Jiang, Li
    Li, Xiaohong
    Lu, Qingbo
    Yuan, Jin
    He, Yongzheng
    Masters, Andi
    Jones, David
    Yates, Charles
    Clapp, D. Wade
    NEURO-ONCOLOGY, 2018, 20 : 87 - 87
  • [2] CYCLIC AMP SUPPRESSION COOPERATES WITH NF1 LOSS TO PROMOTE TUMOR FORMATION AND GROWTH IN A GENETICALLY ENGINEERED MOUSE MODEL OF NF1 OPTIC GLIOMA
    Warrington, Nicole
    Hegedus, Balazs
    Goldhoff, Patricia
    Gianino, Scott
    Perry, Arie
    Gutmann, David
    Rubin, Joshua
    NEURO-ONCOLOGY, 2008, 10 (05) : 852 - 852
  • [3] The Jak1/2 inhibitor AZD1480 suppresses tumor growth and metastasis in genetically engineered mouse models of PTEN-deficient prostate cancer
    De Velasco, Marco A.
    Kura, Yurie
    Ando, Naomi
    Fukushima, Emiko
    Hatanaka, Yuji
    Oki, Takashi
    Yoshimura, Kazuhiro
    Nozawa, Masahiro
    Davies, Barry R.
    Huszdar, Dennis
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2016, 76
  • [4] Pre-Activation of Toll-Like Receptor 2 Enhances CD8+ T-Cell Responses and Accelerates Hepatitis B Virus Clearance in the Mouse Models
    Lin, Yong
    Huang, Xuan
    Wu, Jun
    Liu, Jia
    Chen, Mingfa
    Ma, Zhiyong
    Zhang, Ejuan
    Liu, Yan
    Huang, Shunmei
    Li, Qian
    Zhang, Xiaoyong
    Hou, Jinlin
    Yang, Dongliang
    Lu, Mengji
    Xu, Yang
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [5] p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer
    Powell, Emily
    Shao, Jiansu
    Yuan, Yuan
    Chen, Hsiang-Chun
    Cai, Shirong
    Echeverria, Gloria V.
    Mistry, Nipun
    Decker, Keith F.
    Schlosberg, Christopher
    Do, Kim-Anh
    Edwards, John R.
    Liang, Han
    Piwnica-Worms, David
    Piwnica-Worms, Helen
    BREAST CANCER RESEARCH, 2016, 18
  • [6] p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer
    Emily Powell
    Jiansu Shao
    Yuan Yuan
    Hsiang-Chun Chen
    Shirong Cai
    Gloria V. Echeverria
    Nipun Mistry
    Keith F. Decker
    Christopher Schlosberg
    Kim-Anh Do
    John R. Edwards
    Han Liang
    David Piwnica-Worms
    Helen Piwnica-Worms
    Breast Cancer Research, 18
  • [7] SYNCAR: An Engineered IL-2/IL-2R-system That Selectively Enhances CD19 CAR T Cells to Deplete B Cells and Provide Therapeutic Benefit in SLE and RA Mouse Models Without Lymphodepletion
    Jung, Ethan
    Semana, Marie
    Cheng, Ivan
    Silva, Helena
    Vivona, Sandro
    Singh, Somya
    Bauer, Michele
    Ali, Mohammed
    Rosas, Henry
    Chang, Woei
    Rokkam, Deepti
    Lupardus, Patrick
    Oft, Martin
    Aspuria, Paul-Joseph
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 167 - 168
1